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Abstract
The transient receptor potential melastatin 4 (TRPM4) is a Ca2+-activated nonselec-
tive cation channel linked to human cardiac diseases. The human mutation K914R 
within TRPM4’s S4-S5 linker was identified in patients with atrioventricular block. 
During UV-flash-mediated Ca2+ transients, TRPM4K914R generated a threefold aug-
mented membrane current concomitant with 2 to 3-fold slowed down activation and 
deactivation kinetics resulting in excessive membrane currents during human cardiac 
action potentials. Mutagenesis of K914 paired with molecular modeling suggested 
the importance of the nanoscopic interface between the S4-S5 linker, the MHR4-, 
and TRP-domain as a major determinant for TRPM4’s behavior. Rational mutagen-
esis of an interacting amino acid (R1062Q) in the TRP domain was able to offset 
K914R`s gain-of-function by zipping and unzipping of this nanoscopic interface. In 
conclusion, repulsion and attraction between the amino acids at positions 914 and 
1062 alters the flexibility of the nanoscopic interface suggesting a zipping and unzip-
ping mechanism that modulates TRPM4’s functions. Pharmacological modulation of 
this intramolecular mechanism might represent a novel therapeutic strategy for the 
management of TRPM4-mediated cardiac diseases.
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1 |  INTRODUCTION
The transient receptor potential melastatin 4 (TRPM4) channel 
is a Ca2+-activated nonselective cation channel with a wide-
spread expression pattern.1 In the heart, expression of TRPM4 
is prominent in the Purkinje fibers and nodal tissues.2,3 Genetic 
variants in the TRPM4 gene have been linked to various car-
diac diseases including cardiac conduction defects, Brugada 
syndrome, and long QT syndrome.2-5 Both, gain- and loss-of-
function were reported for these TRPM4 variants.3 In a gain-of-
function variant E7K, linked to progressive familial heart block 
type 1, the TRPM4E7K protein was reported to accumulate in 
the plasma membrane as a result of aberrant SUMOylation of 
the protein.2 A recent study suggested an altered degradation 
rate of the proteins as a novel mechanism for cardiac conduc-
tion diseases.6 As shown recently, gain-of-function mutations in 
the S6 segment of TRPM4 channel associated with human skin 
diseases depicted an increased sensitivity to intracellular Ca2+.7 
Our previous study revealed an isolated reduction in the Ca2+-
dependent deactivation of the human mutation TRPM4A432T as 
a novel etiology in the pathogenesis of cardiac arrhythmia such 
as cardiac conduction block.8
Recent reports on TRPM4’s structure revealed an inverted 
crown-like architecture of the functional tetrameric channel 
protein, containing six transmembrane, the N- and C-cytosolic 
domains.9,10 The most prominent feature of TRPM4 is its long 
N-terminal domain including four TRPM Homology Regions 
(MHR1-4), which are envisaged to interact with the TRP and 
the C-terminal domain.11,12 Another feature of the TRPM4 pro-
tein is that its TRP domain is not continuous but fragmented 
into two helices. The longer one, referred as the TRP helix, fol-
lows the transmembrane helix S6 and runs parallel to the cyto-
solic face of the plasma membrane. The shorter one, referred to 
as the TRP re-entrant connects to the C-terminal domain.10,11 
The first four transmembrane domains (S1-S4) are followed by 
the pore-forming domains (S5-S6). The S4-S5 linker, connect-
ing the S1-S4 helices and S5-S6 pore-forming domain, is best 
known for its putative contribution to channel's gating. In volt-
age-gated ion channels, channel opening is often coupled to the 
movement of S1-S4 voltage sensors through the S4-S5 linker 
helix, which leads to splay of the lower S6 helix and opens the 
activation gate.13 In TRPV1, the S4-S5 linker and S6 interact 
through the hydrogen bonding between two residues, D576 
in the S4-S5 linker and M684 in S6, to open TRPV1’s lower 
gate.14 In TRPV4, S4-S5 linker is reported to play a role in both 
opening15 and stabilizing channel's closed state.16
Interestingly, TRP’s S4-S5 linker became a hot spot for 
human mutations causing different channelopathies. Two 
missense mutations (G573S and W692G) of TRPV3 were 
identified in patients with Olmsted syndrome.17 A gain-of-
function mutation of TRPA1’s S4-S5 linker was reported 
in the familial episodic pain syndrome.18,19 At least eight 
of these known human TRPV4 mutants (Y591C, F592L, 
R594H, R594S, L596P, G600W, Y602C, I604M) locate 
within the S4-S5 linker, have been linked to various skele-
tal dysplasia and neuropathies.20 Stallmeyer and co-work-
ers identified a mutation K914R in the S4-S5 linker of the 
TRPM4 channel in two patients from the same family.4 The 
son suffered from severe, congenital atrioventricular block 
(AVB) 3° and required implantation of a cardiac pacemaker 
for more than 30 years, while his father carrying the same 
mutation presented a less severe phenotype with a normal 
atrioventricular conductance and an asymptomatic right bun-
dle branch block (RBBB).4 However, a functional character-
ization of TRPM4K914R and the underlying etiology for the 
cardiac conduction block are still lacking.
In the present study, we employed a combination of elec-
trophysiology, intracellular Ca2+ recordings, and rapid ma-
nipulations of Ca2+ by UV-flash photolysis of caged Ca2+ 
compounds8 to gain deeper insights into the possible mo-
lecular mechanisms of a human TRPM4 mutation (K914R) 
mediating cardiac conduction diseases. Our results strongly 
suggest an etiology in TRPM4-related cardiac conduction 
diseases with aberrant intramolecular interfaces within the 
mutated TRPM4 channel resulting in zipping and unzipping 
of these nanodomains. We identified the S4-S5 linker—
TRP domain—MHR4 interface to substantially modulate 
TRPM4’s Ca2+-dependent functional properties. Altogether, 
the human K914R mutation appears to be a gain-of-function 
mutation mediated by intramolecular weakening of this im-
portant interface.
2 |  MATERIALS AND METHODS
2.1 | Cell culture and expression
Human embryonic kidney (HEK293) cells were cultured in 
Dulbecco's modified Eagle's culture medium supplemented 
with 10% (v/v) FBS, and a cocktail of 100 U/mL penicillin 
and 100 μg/mL streptomycin. Cells were maintained at 37°C 
in a humidity-controlled incubator with 5% CO2. Prior to the 
experiments cells were seeded on 20 mm diameter glass cov-
erslips in 12-well plates for electrophysiological recording or 
6-well plates for western blots. 24 hours after seeding, cells 
were transiently transfected with 1  μg/well given plasmid 
by NanoJuice (Novagen, USA) following the manufacture´s 
instruction. After incubation for another 48-72  hours, suc-
cessful transfection can be verified by the expression of 
TagRFPT.
2.2 | TRPM4 mutagenesis
The complete human wild-type TRPM4 cDNA was kindly 
provided by Dr Ulrich Wissenbach and Prof. Flockerzi 
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(GenBank: AF497623.1) and then, fused with a fluorescence 
protein TagRFPT at the C-terminus into a pCR259 vector. 
Mutations were obtained by a two-step PCR protocol as 
previously described,21 and the mutated clones were re-se-
quenced before further experimental use.
2.3 | Electrophysiology
Electrophysiological recordings were performed in the 
whole-cell patch clamp configuration with an EPC-10 am-
plifier (HEKA Electronic, Germany). Patch pipettes had a 
resistance of 3-5  MΩ with intracellular solution contained 
(in mmol/L): 140 CsCl, 1 MgCl2, 10 HEPES, 1 NP-EGTA, 
0.5 CaCl2, and 0.15 Fluo-4FF. The pH was adjusted to 7.2 
with CsOH and the free Ca2+ concentration was determined 
in independent experiments by Fura-2 in vitro. Extracellular 
solution contained (in mmol/L): 140 NaCl, 1 MgCl2, 1.8 
CaCl2, 10 HEPES, and 10 Glucose, pH 7.35 was adjusted 
with NaOH. The holding potential was set to −60 mV, the 
TRPM4 currents were recorded at +80 mV.
2.4 | UV-flash assay
The UV-flash assay was described in details recently.8 In brief, 
a UV-flash lamp (RAPP OptoElectronic GmbH, Germany) was 
coupled to the inverted microscope (TE2000-U, Nikon, Japan). 
Brief high-intensity flashes were used to uncage Ca2+ from 
the Ca2+-caged compound NP-EGTA (cat. N6802, Thermo 
Fisher). Excitation of the Fluo-4FF was performed centered 
around 480 nm (±5 nm) with a monochromator (PolyChrome 
V, TILL, Photonics, Germany) and the emission was col-
lected by photodiode-based epifluorescence hardware (TILL, 
Photonics, Germany) via a 515 nm long-pass filter. The Ca2+ 
concentration was calculated as described previously.8
2.5 | Measurement and calculation of the 
free Ca2+ concentration
The procedure to construct current versus Ca2+ concentra-
tion relationship and the determination of the activation and 
deactivation was reported recently.8
The pipette solution without NP-EGTA and Ca2+ was ali-
quots into 100 μL with 5 mM EGTA. Then different amount 
of Ca2+ was added to the solution for the final concentrations 
(mM): 0.1, 0.3, 0.5, and 0.7. Then these solutions were mea-
sured separately by Fura-2 and Fluo-4, from which we could 
know the Fluo-4 fluorescence intensity of these solutions as 
well the corresponding free Ca2+ concentrations. Based on 
these results two stand curves as shown in following Figure S3. 
Then the fluorescence intensities of TRPM4 pipette solution 
with NP-EGTA (1  mM) and Ca2+ (0.5  mM) concentrations 
were measured by Fluo-4 (Figure S3A horizontal dashed line). 
According to the Fluo-4 fluorescence intensity curve, the cor-
responding Ca2+ was 0.31 mM (see Figure S3A vertical dashed 
line), which was also depicted in the Figure S3B (vertical dashed 
line), the corresponding free Ca2+ concentration was calculated 
according to the Fura-2 standard curve (see Figure S3B hori-
zontal dashed line), that was about 100 nM.
In experiments, free Ca2+ concentration was calculated 
as described in our previous publication.8[Ca2+]  =  KR[(K/
[Ca2+]0 + 1)-R]. R is the fluorescence ratio and K is the disso-
ciation constant for Fluo-4FF. [Ca2+]0 is the Ca
2+ concentration 
of the pipette solution that was determined in independent ex-
periments in small aliquots in vitro as described as above.
2.6 | Action potential playback
The human-induced pluripotent stem cell-derived cardiac 
myocytes (hiPS-CMs) were generated and cultured as de-
scribed earlier.22 Spontaneous action potentials were re-
corded from these cells with Tyrode solution containing 
(mM): 137 NaCl, 5.4 KCl, 10 HEPES, 10 Glucose, 1 MgCl2, 
1.8 CaCl2, pH was set to 7.4 with NaOH and the internal so-
lution contains (mM): 135 KCl, 10 NaCl, 2 MgCl2, 1 EGTA, 
10 HEPES, 3 MgATP, pH was adjusted to 7.2 with KOH. 
Typical ventricular-like action potential waveforms were se-
lected as the command voltage template in voltage-clamp, 
while triggering the UV-flashes to induce Ca2+ release and 
recording the membrane currents as well as the intracellular 
Ca2+ concentration by patch clamp simultaneously.
2.7 | Surface biotinylation and Western blot
Cells were incubated with Sulfo-NHS-LC Biotin (1  mg/mL, 
gently shaking for 30  minutes at 4°C, cat. 21335, Thermo 
Fisher) to label all the surface proteins as described by the 
manufacture's instruction. To precipitate biotinylated proteins, 
supernatant containing proteins was incubated with Dynabeads 
MyOne Streptavidin C1 (cat. 65001, Thermo Fisher) for 30 min-
utes at 4°C following the protocol suggested by manufacture. 
Proteins were separated by NuPAGE 3%-8% Tris-Acetate Gels 
(EA03755BOX, Thermo Fisher) and detected with anti-ta-
gRFPT (cat. #AB234, Evrogen), anti-Na/K+ATPase α-1N-15 
(cat. #sc-16041, Santa Cruz Biotechnology) and anti-actin (cat. 
#sc-8432, Santa Cruz Biotechnology) antibodies.
2.8 | Confocal imaging
A TSC SP5 Ⅱ(Leica Microsystems, Wetzlar, Germany) con-
focal microscope based on an inverted microscope with a 
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high-speed resonating X-scanner and spectral emission detec-
tion was used for acquisition of confocal images. Excitation 
of TagRFPT was achieved with the 561 nm line of a solid 
state laser and images (1024 × 1024 pixels) were acquired for 
emission wavelengths above 565 nm with a standard PMT. 
The Leica Application Suite software (ver. 2.4) was used to 
control the confocal system.
2.9 | Model generation
Molecular dynamic simulations are performed using Materials 
Studio 6.0 software (Accelrys Inc, USA). The Forcite module 
was used to simulate the possible conformations and optimize 
the simulation under Compass field. Energy minimization was 
carried out using the steepest descent minimization of 1000 
steps followed by 9000 step conjugate gradient minimizations 
at an ambient pressure of 1 bar and a constant temperature of 
300 K. The step size was maintained at 1 fs. After those steps, 
the three-dimensional models were prepared using PyMOL 
Molecular Graphics System (Version 1.5.0.4, Schrödinger, 
LLC, New York, NY, USA) and Coot30,23 based on the struc-
ture of human TRPM410 (PDB code: 5WP6).
2.10 | Statistics
Data are represented as the mean ± SEM. Sample distribution 
was tested for normality using D’Agostino & Pearson test in 
Prism 7.0 software (GraphPad Software Inc, USA). The un-
paired two-tailed Student's test was used to analyze wild type 
and mutants with a probability value below 0.05 (P <  .05) 
considered as significant. P values are given for each statisti-
cal comparisons in the figure panels. “n”-numbers are given 
as the number of investigated cells (patch-clamp) or transfec-
tions (western blot). The consistent results are confirmed by 
least two independent repeats of measurements.
3 |  RESULTS
3.1 | K914R slows the gating properties 
of TRPM4 channel and increases membrane 
current without altering protein's expression
To study the functional consequences and explore possible 
disease related molecular mechanisms of the K914R muta-
tion, we transiently expressed wild-type TRPM4 (TRPM4wt) 
and TRPM4K914R in HEK293 cells and investigated their 
Ca2+-dependent behavior with the Ca2+ uncaging approach 
described recently.8 We found that trains of UV-flashes in-
duced approximately three fold more membrane current in 
the TRPM4K914R mutant when compared to the TRPM4wt 
protein (455.9 ± 56.3 pA/pF, n = 11 vs 154.1 ± 13.0 pA/
pF, n = 11, respectively, Figure 1A,B) while no significant 
change in KD,Ca was identified (Figure 1C). When analyzing 
their activation and deactivation properties, we noticed that 
the TRPM4K914R mutation displayed slower kinetics in both, 
activation (291.8 ± 37.2 ms (wt, n = 16) vs 585.8 ± 99.2 ms 
(mutation, n  =  13); Figure  1D) and deactivation processes 
(2.2 ± 0.2 seconds (wt, n = 13) vs 6.7 ± 0.6 seconds (muta-
tion, n = 14); Figure 1E). Expression differences were not 
the reason for the vastly different plasma membrane currents 
found, because our immunoblotting experiments indicated no 
significant difference between the expression of TRPM4wt 
and TRPM4K914R proteins on both, the global and the plasma 
membrane level (Figure 1F,G, respectively). These data in-
dicated that the conservative substitution from lysine to argi-
nine at position 914 in the S4-S5 linker severely affected the 
normal function of TRPM4 channels.
To further analyze the putative contribution of the K914R 
mutant to changes in ionic currents during human cardiac ac-
tion potentials, we recorded action potentials from human-in-
duced pluripotent stem cells-derived cardiac myocytes 
(hiPSC-CMs) with ventricular identity as described earlier8 
and used those voltage recordings as templates for action 
potential playback in HEK293 cells expressing TRPM4wt or 
TRPM4K914R channels (Figure 2A). UV-flash-mediated Ca2+ 
uncaging (Figure 2B) was triggered immediately following 
the onset of the action potential (Figure 2A, marked by the 
vertical dashed lines) to mimic the Ca2+ increase during a 
cardiac action potential. This experimental regime resulted in 
large and dynamic membrane currents that almost returned 
to baseline values between consecutive action potentials for 
the wt protein as shown by the black trace in Figure 2C. In 
contrast to that, the K914R mutant displayed a substantially 
distorted and increased the membrane current (red trace in 
Figure 2C). We compared the currents at the peak of the ac-
tion potential (indicated by the labels above the action po-
tentials in Figure 2A) and at full repolarization (labels below 
the action potentials in Figure 2A) in the panels Figure 2D,E, 
respectively. These data strongly suggest that once activated 
by Ca2+ TRPM4K914R generated excessive, accumulating 
membrane currents with diminished deactivation between 
consecutive human action potentials. Such persistent mem-
brane currents may severely deform the shape of human ac-
tion potentials, alter the diastolic membrane potential and in 
this way directly contribute to the pathology of human car-
diac conduction diseases.
3.2 | K914G and K914E render 
TRPM4 non-functional
Amino acid K914 is located in the S4-S5 linker region (see 
Figure 3A), which was suggested as an important domain for 
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the function of TRP channels.20 To further substantiate this 
role, we replaced the lysine, like arginine a positively charged 
basic amino acid by amino acids of distinct physicochemical 
properties, by glycine, the simplest nonpolar aliphatic amino 
acid, and glutamate, an acidic, negatively charged amino 
acid (Figure  3B), and expressed those TRPM4 variants in 
HEK293 cells. Neither the glycine nor the glutamate substitu-
tion was able to generate substantial membrane currents that 
were distinguishable from the background membrane current 
found in non-transfected HEK293 cells (Figure 3C). When 
we analyzed the expression and distribution of the TRPM4-
TagRFPT variants in HEK293 cells and we verified both, 
ready expression of the protein indicated by the substantial 
TagRPFT fluorescence and strong plasma membrane decora-
tion (Figure 3D).
Following from these unexpected findings, we investi-
gated the putative molecular mechanism for that behavior. 
Based on the electron cryo-microscopy structure of TRPM4 
reported recently,12 residue K914 within the S4-S5 linker in-
teracts with residues in the TRPM Homology Region (MHR) 
4 domain (Q673, T677, W680 and W681) and the TRP helix 
(W1058, K1059 and R1062) as depicted in Figure 4A. The 
residue K914 (positive charge) interacts with T677 through 
hydrogen bonds and with all other amino acids via hydro-
phobic interactions to form a stable functional interdomain 
interface (Figure  4A). Molecular dynamic simulation can 
F I G U R E  1  TRPM4K914R slows Ca2+-dependent channel gating and enhances membrane current without altering the protein's expression. 
A, Typical currents recorded in HEK293 cells transiently expressing TRPM4wt (black) and TRPM4K914R (red) as well as the Ca2+ concentration 
(gray) during a train of UV-flashes (turquoise triangles). B, Statistical analysis of the maximum membrane current density from TRPM4wt and 
TRPM4K914R (n = 11 cells for each group). C, Typical membrane vs Ca2+ relationships of TRPM4wt and TRPM4K914R (right) and statistical 
analysis (left) (n = 14 cells for TRPM4wt and n = 10 cells for TRPM4K914R). D, Typical normalized activation currents (lower left) activated by 
Ca2+ transients (upper left) induced by UV-flash and statistical analysis of activation time constants (right) (n = 16 cells for TRPM4wt and n = 13 
cells for TRPM4K914R). E, Typical normalized deactivation currents (lower left) and statistical analysis of deactivation time constants (lower right) 
as well as the corresponding Ca2+ decay traces (upper left) and the decay time constants (upper right) (n = 13 cells for TRPM4wt and n = 14 cells 
for TRPM4K914R). F, Typical western blot of whole cell lysates of TRPM4wt and TRPM4K914R (left) as well as the statistical analysis (right) (n = 4 
cultures for TRPM4wt and n = 5 culture for TRPM4K914R). G, Typical western blot of TRPM4wt and TRPM4K914R on the plasma membrane (left) 
and the statistical analysis (right) (n = 4 cultures for TRPM4wt and n = 5 culture for TRPM4K914R). Data information: In (B-G), data are presented 
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calculate the total energy of given protein structures.24 We 
found that the energy contents of the crystal structures de-
rived for the mutated TRPM4 variants were similar to that of 
the wild-type human TRPM4 structure (PDB code: 5WP6). 
This indicated an equal stability and rationality between 
the TRPM4wt structure and those of the mutant proteins 
(Table S1). In the human K914R mutant, arginine apparently 
snaps into a molecular pocket formed by the MHR4 and TRP 
helix due to its more spacious guanidinium group providing 
three asymmetrical nitrogen atoms. As a consequence of that 
it may deform the S4-S5 linker leading to increased interac-
tions with additional amino acids (hydrophobic interactions 
with W680, W681, P689, I690, W691, W1058, and R1062 
and hydrogen bonds with T677 and T687). These extra in-
teractions appear to lock the S4-S5 linker in a rigid unzipped 
position (Figure 4B). With glycine at site 914, the existing 
interactions were lost, which may disrupt the function of the 
TRPM4 channel (Figure 4C). In comparison to the wt lysine 
(K914), glutamate enables an increased number of hydrogen 
bonds and less hydrophobic interactions with its surround-
ing amino acids (Q673, R1062, and K1059: hydrogen bonds; 
W680, W681 T677, and W1058: hydrophobic interaction). 
This situation might “lock” the entire domain structure in 
this “zipped” position (Figure  4D) to render the channel 
non-functional. Based on these analyses, we propose that 
alterations of the amino acid at position 914 might render 
TRPM4 mal-functional or non-functional due to a disruption 
or modulation of the interaction between the S4-S5 linker and 
surrounding domains such as the MHR4 domain and the TRP 
helix.
3.3 | An artificial amino acid exchange 
(R1062Q) in the TRP box offsets the 
malfunction caused by the K914R mutation
TRPC, TRPM, and TRPV channels contain a TRP domain—
a ~25 residue conserved sequence- following the S6 seg-
ment at the C-terminal end of the proteins. Therein, the 
most conserved TRP box motif consists of six amino acids 
(EWKFAR) in the TRPC subfamily or five amino acids 
(WKFQR) in the TRPM subfamily. In TRPV4, the S4-S5 
F I G U R E  2  TRPM4K914R generates excessive membrane currents during human ventricular action potentials. A, Action potentials recorded 
from the ventricular-like human-induced pluripotent stem cell-derived cardiac myocyte (hips-CM). B, Intracellular Ca2+ concentration during the 
experimental regime. C, TRPM4wt (black) and TRPM4K914R (red) mediated membrane current traces resulting from the command voltage shown in 
(A) and Ca2+ concentration (B). D, Statistical analysis of the currents in (C). Currents were probed at the points indicated by the numbers above the 
action potentials in (A) (n = 9 cells for both groups). E, Statistical analysis of the currents in (C). Currents were probed at the points indicated by 
the numbers below the action potentials (full repolarization) in (A) (n = 9 cells for both groups). Data information: In (D-E), data are presented as 
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linker has been suggested to interact with the TRP domain to 
modulate the channel's gating kinetics.16 Based on the electro 
cryo-microscopy structure of the TRPM4 channel, the hydro-
phobic interactions between the K914 in S4-S5 linker and the 
three residues (W1058, K1059, and R1062) in the TRP box 
(Figure S2) may suggest similar interactions between S4-S5 
linker and TRP domain for the TRPM4 channel. Nilius and 
co-workers reported an increased deactivation of the TRPM4 
channel after introducing the R1062Q mutation25 and we 
wondered whether this mutation (R1062Q) in the TRP box 
is able to rescue the current phenotype of the TRPM4K914R 
mutation.
We characterized the behavior of TRPM4R1062Q (Figure 5) 
and found that TRPM4R1062Q displayed a decreased mem-
brane current (52.1 ± 7.6 pA/pF, n = 14, Figure 5A,B) when 
compared to that of TRPM4wt (115.1 ± 20.4 pA/pF, n = 12) 
without altering the protein's global and plasma membrane 
expression (Figure 5F,G, respectively). No significant differ-
ence in the current's Ca2+ sensitivity was detected (Figure 5C) 
but membrane currents of TRPM4R1062Q were character-
ized by a faster activation and deactivation time constants 
(133.0 ± 9.5 ms, n = 9 and 2.2 ± 0.1 seconds, n = 18, respec-
tively), when compared to the wt channels (211.7 ± 21.7 ms, 
n = 12 and 3.0 ± 0.2 seconds, n = 14) (Figure 5D,E).
We then tested the double mutant TRPM4K914R+R1062Q and 
found that it could indeed partially offset altered parameters 
of the TRPM4K914R mutation. As shown in Figure 6A,B, the 
membrane current was reduced by 26% (from 199.8 ± 17.2 
pA/pF, n  =  13 in TRPM4K914R to 147.2  ±  14.1  pA/pF, 
n = 14 in TRPM4K914R+R1062Q) while the KD,Ca remained un-
changed (Figure  6C). Notably, for TRPM4K914R+R1062Q the 
activation (Figure 6D) and deactivation (Figure 6E) became 
faster than that of the human single mutation TRPM4K914R 
(493.6 ± 42.7 ms, n = 11 and 3.1 ± 0.1 seconds, n = 13 vs 
F I G U R E  3  TRPM4K914G and TRPM4K914E variants render the channel non-functional. A, Schematic representation of TRPM4’s 
membrane topology indicating the position of human mutation K914R. B, Structure and properties of TRPM4wt, TRPM4K914R, TRPM4K914G, 
and TRPM4K914E. Color coding indicating by the color of rectangles. C, Currents of TRPM4 variants activated by a series of UV-flash-induced 
Ca2+ jumps (gray, left) and the statistical analysis of the membrane current density (right) (n = 11 cells for wt, n = 8 cells for K914G, n = 10 for 
K914E, and n = 8 for naíve HEK cells). D, Confocal section through the middle of HEK293 cells expressing TRPM4 variants as indicated. Data 
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654.3 ± 46.4 ms, n = 12 and 7.4 ± 0.4  seconds, n = 14). 
Western blot analysis showed that for both proteins, the 
global as well as the plasma membrane expression were un-
changed (Figure 6F,G). Nevertheless, we observed that the 
TRPM4K914R+R1062Q channel still exhibited the increased cur-
rent density, the slower activation, and deactivation kinetics 
reminiscence of the K914R single mutation when compared 
to TRPM4wt (Figure S1). These findings indicate that the in-
troduced mutation R1062Q in the TRP box could partially 
offset the aberrant functions resulting from the human muta-
tion K914R in the S4-S5 linker.
3.4 | The interface between the S4-S5 
linker, the MHR4 domain, and the TRP 
domain modulate TRPM4’s properties
The electron cryo-microscopy structure of TRPM4 chan-
nel10 suggests that in the human TRPM4wt channel hydro-
phobic interactions can be formed between K914 in the 
S4-S5 linker and R1062 in the TRP box. We suggest that 
these interactions represent the overall forces for a stable 
protein structure and maintain a proper distance between 
the S4-S5 linker and TRP domain (Figure  7A) that war-
rant normal TRPM4 gating (Figure 1, in black). The switch 
from the positively charged arginine (R) to the polar and 
uncharged glutamine (Q) at position 1062 induces H-bonds 
between lysine914 and glutamine1062. This stronger interac-
tion reduces the critical distance between the TRP domain 
and the S4-S5 linker and lock them in a zipped position 
when compared to the wt situation (compare Figure 7A,B) 
resulting in an altered function with speed-up activation 
and deactivation kinetics (Figure 5 in brown). In contrast, 
the hydrophobic interaction due to the electrostatic force 
between arginine914 and arginine1062 in TRPM4K914R mu-
tant results in a repulsion between the S4-S5 linker and 
the TRP domain (Figure 7C). Consequently, the distance 
between these two domains widens and unzipped the S4-S5 
linker causing a gain-of-function with slowed down activa-
tion and inactivation kinetics. Eventually, H-bonds between 
arginine914 and glutamine1062 in the TRPM4K914R+R1062Q 
variant partially offset the repelling forces modeled for the 
TRPM4K914R mutant and close and zip the gap between the 
S4-S5 linker and the TRP domain (Figure  7D) resulting 
F I G U R E  4  The amino acid at position 914 modifies the interface between the S4-S5 linker, TRP domain, and MHR4 domain in the TRPM4 
protein. A-D, Models of the S4-S5 linker, TRP domain and MHR4 domain interface calculated for various amino acids at position 914: lysine in the 
wt protein (A), arginine in the K914R mutation (B), glycine in the K914G mutation (C) and glutamic acid in the K914E mutation (D). Dashed lines 
indicate putative coordinating amino acid interactions (red dashed lines: hydrophobic interactions; blue dashed lines: hydrogen bonds). Structures 
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in a shift of the channel's behavior toward “wt behavior” 
(see Figure 6). Residues involved in the intramolecular in-
terface of S4-S5 linker, TRP domain, and MHR4 domain 
are shown in Figure S2. Modeling energy evaluations are 
shown in Table S1. These structural modeling results offer 
a molecular mechanism for the channel's properties pre-
sented above and strongly suggest a very important interac-
tion between the S4-S5 linker region and the TRP domain 
for the proper gating of the TRPM4 channel.
4 |  DISCUSSION
In the present study, we revealed that the TRPM4K914R mu-
tant found in patients with atrioventricular-block displays 
aberrant behavior in Ca2+-induced gating with 2 to 3-fold 
slowed-down Ca2+-dependent activating and deactivating 
kinetics and a substantially increased membrane current 
density. The increased membrane current was not a result 
of an altered global or plasma membrane protein expression 
when compared to the wt protein suggesting that it might 
be a direct result of the altered gating kinetics rather than 
an increased protein accumulation.2 To gain additional in-
sight into the putative contribution of this mutation to ab-
errant cardiac electrophysiology, we recorded native action 
potentials from ventricular-like hiPSC-CMs and used these 
voltage traces as templates in action potential play-back ex-
periments. These studies demonstrate K914R’s potential in 
substantially altering the shape and time course of human ac-
tion potentials and thus suggests a novel disease mechanism 
F I G U R E  5  Amino acid at position 1062 in the TRP domain modulates TRPM4’s properties. A, Typical currents of cells transiently expressing 
TRPM4wt (black) and TRPM4R1062Q (brown) and the intracellular Ca2+ concentrations (gray) during a series of UV-flashes. B, Statistical analyses 
of the maximum membrane current densities of TRPM4wt and TRPM4R1062Q (n = 12 cells and n = 14 cells, respectively). C, The current vs Ca2+ 
concentration relationship (left) and statistical analyses (right) (n = 11 cells for each group). D, Normalized activation currents (middle) elicited by 
a Ca2+ jump (top) and the statistical analyses of activation time constants (bottom) (n = 9 cells for TRPM4wt and n = 12 cells for TRPM4R1062Q). 
E, Normalized deactivation currents (middle) as well as the Ca2+ decay traces (top) and statistical analyses of deactivation time constants (bottom) 
(n = 14 cells for TRPM4wt and n = 18 cells for TRPM4R1062Q). F, Western blot of whole cell lysates of TRPM4wt and TRPM4R1062Q (left) and 
the statistical analyses (right) (n = 4 cultures for TRPM4wt and n = 5 cultures for TRPM4 R1062Q). G, Western blot of plasma membrane protein 
of TRPM4wt and TRPM4R1062Q (left) and the statistical analyses (right) (n = 4 cultures for TRPM4wt and n = 5 cultures for TRPM4 R1062Q). Data 
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for TRPM4-dependent AV-blocks in patients: aberrant Ca2+-
dependent gating through intramolecular domain zipping and 
unzipping.
For more than a decade the importance of the S4-S5 linker 
in the control of voltage-dependent gating of TRPM4 has 
been suggested.26 TRPM4 and its related proteins TRPM2, 
TRPM5, and TRPM8, all contain two basic amino acids in 
this S4-S5 linker. Neutralizing the positively charged residues 
(R842 and K856) in TRPM8 shift its voltage dependence.27 
Our data provides direct functional evidence that the S4-S5 
linker is a modulator of TRPM4’s Ca2+-dependent gating 
(Figure 1) highlighting its possible importance for TRPM4’s 
behavior. To investigate the role of this region in greater 
detail, we changed the positively charged residue lysine to 
the nonpolar residue glycine and to the negatively charged 
glutamate. Both variants lacked any Ca2+-dependent mem-
brane currents. Two possible mechanisms can be envisaged. 
Either direct Ca2+-binding pocket of TRPM4 or indirect 
Ca2+-dependent gating of TRPM4 is modified by these mu-
tations. A previous report investigating the E1068Q amino 
acid exchange within the TRP domain depicted a reduced 
Ca2+-sensitivity of the TRPM4 channel because of its steric 
proximity to the path leading to the putative Ca2+-binding 
sites from the cytoplasmic space.12 Four amino acids have 
been proposed to coordinate Ca2+ binding (glutamate828, 
glutamine831 from S2 and asparagine865, aspartate868 from 
S3).12 Because these coordinating amino acids appear further 
away from the S4-S5 linker and the mutation TRPM4K914R 
did not affect the Ca2+ sensitivity of the TRPM4 channel 
(Figure 1C), we suggest that position 914 is not a site directly 
F I G U R E  6  R1062Q partially offsets the aberrant properties of the K914R mutation in TRPM4. A, Typical currents of cells transiently 
expressing TRPM4K914R (red) and TRPM4R1062Q (magenta) and the intracellular Ca2+ concentrations (gray) during a series of UV-flashes. 
B, Statistical analyses of the maximum membrane current densities of TRPM4K914R and TRPM4K914R+R1062Q (n = 13 cells and n = 14 cells, 
respectively). C, The current vs Ca2+ concentration relationship (left) and statistical analyses (right) (n = 10 cells for TRPM4K914R and n = 14 cells 
for TRPM4K914R+R1062Q). D, Normalized activation currents (middle) elicited by UV-flash-induced Ca2+ jumps (top) and the statistical analyses of 
activation time constants (bottom) (n = 12 cells for each group). E, Normalized deactivation currents (middle) as well as the Ca2+ decay traces (top) 
and statistical analyses of deactivation time constants (bottom) (n = 14 cells for TRPM4K914R and n = 13 cells for TRPM4K914R+R1062Q). F, Western 
blot of whole cell lysates of TRPM4K914R and TRPM4K914R+R1062Q (left) and the statistical analyses (right) (n = 4 cultures for each group). G, 
Western blot of plasma membrane protein of TRPM4K914R and TRPM4K914R+R1062Q (left) and the statistical analyses (right) (n = 4 cultures for each 
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modulating TRPM4’s Ca2+-binding pocket. As reported for 
the TRP family in general, the S4-S5 linker plays a crucial 
role in the channel's gating kinetics through an interaction 
with the TRP domain.16,20 A “conformational” changes in-
duced by peptides targeting TRP domain in TRPV1 channel 
has been reported to lead to gate opening.28 In the structure 
of the TRPM4 channel, the S4-S5 linker indeed seems to 
directly interact with the TRP domain and the MHR4 do-
main.10-12 Our molecular modeling of the amino acid sub-
stitutions suggests an alteration of the nanoscopic interface's 
stability and zipping state (Figure  4). This may render the 
channel non-functional by destroying essential interactions 
between the internal domains (S4-S5 linker, MHR4, and 
TRP domain) deteriorating the gating kinetics, specifically 
channel opening and closing but leaving Ca2+-binding sites 
untouched. Even though we did not observe any changes in 
the Ca2+ sensitivity of the TRPM4 variants, it has to be re-
alized that the Ca2+ binding process of the TRPM4 protein 
is modulated by multiple factors, such as ATP and PKC-
dependent phosphorylation.29 Ca2+- calmodulin binding sites 
at the C terminus have been reported to regulate the Ca2+ 
sensitivity of TRPM4 channels.29 In the structure of TRPM4, 
residues surrounding the putative Ca2+-binding sites might 
also contribute to the coordination of Ca2+ binding.12 Thus, 
it is still uncertain whether the unchanged Ca2+ sensitivity 
observed in our results is directly due to an unaltered Ca2+ 
binding process. Alternatively, the mutations might exert a 
compensatory effect on the regulation processes or the spatial 
arrangement within the molecule itself resulting in an appar-
ently unaltered Ca2+ sensitivity.
In general, the TRP domain is considered important for 
very diverse processes such as channel gating and allosteric 
modulation.30-32 In the TRPM4 channel, the TRP domain dis-
plays extensive interactions with its neighboring domains.11,12 
The interaction between the TRP domain and the N-terminal 
domain is mediated by five residues (K1059, R1062, R1067, 
L1056, and Y1063) and four residues (L655, Q673, T677, and 
R664), respectively.11 The TRP domain putatively interacts 
with the S4-S5 linker through hydrogen bridges similar to those 
found in the TRPV1 and TRPA1 proteins.33-35 In particular, 
F I G U R E  7  The interface between the S4-S5 linker, the TRP domain, and the MHR4 domain modulates TRPM4’s functions. A-D, Models 
of the S4-S5 linker, TRP domain, and MHR4 domain interface calculated for various amino acids at position 914 and 1062 (as indicated). Dotted 
volumes indicate the approximate volume occupied by the indicated amino acids. The red arrows indicate contraction or widening of the S4-S5 
linker—TRP domain interface. Structures were derived from the previously solved structure of the human TRPM4 channel (PDB code 5WP6). S4-
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the N913 in the S4-S5 linker contacts R1062 of the TRP do-
main via hydrogen bonds.11 The invariant residue W1058 in 
the TRP domain is embraced by the S4-S5 linker, forming a 
possible hydrogen bond with T911 in the S4-S5 linker.10 In our 
study, we confirmed the importance of R1062 in that a substi-
tution of the arginine with glutamine caused aberrant TRPM4 
behavior characterized by accelerated Ca2+-dependent activa-
tion and deactivation kinetics and a reduced membrane current 
density (loss-of-function) (Figure  5). Interestingly, molecu-
lar modeling indicated that R1062 and K914 share the same 
interaction interface in the TRPM4 molecule and possibly 
even interact directly. We, therefore, investigated whether the 
R1062Q variant might actually be efficient in offsetting the 
effects seen in the K914R variant. We found that indeed the 
slowed down gating kinetics and the increased membrane cur-
rent density could—at least partially—be “compensated” for 
by the R1062Q amino acid exchange. These findings strongly 
supported our notion that both amino acids K914 and R1062 
not only share the same nanodomain and interact but that this 
particular interaction interface might be a critical determinant 
for TRPM4’s Ca2+-dependent gating (Figure  6). A detailed 
analysis of our molecular modeling of this interaction region 
indeed revealed a possible molecular mechanism modulating 
the channel's behavior. It appears that due to the residues’ in-
teractions, maintaining a precise distance between the S4-S5 
linker and the TRP domain is essential for a normal function of 
the TRPM4 channel. Stronger interactions in the R1062Q vari-
ant appear to close the gap between these structures, lock them 
in a zipped configuration and thus cause a loss of function 
while a weaker interaction as proposed for the K914R variant 
widens the S4-S5 linker—TRP domain gap (unzipping) and 
causes gain-of-function in the TRPM4 protein. Moreover, in 
the K914R variant the S4-S5 linker appears to be locked in 
this “open” or unzipped position. Supporting this notion, the 
double amino acid exchange in the TRPM4K914R+R1062Q vari-
ant results in a reduced repulsion between these domains when 
compared to the human mutation TRPM4K914R and may thus 
partially compensate the kinetic alterations resulting from the 
latter amino acid exchange (Figures 7 and S2).
In conclusion, our study reveals that the mutation 
TRPM4K914R identified in patients with cardiac conduction 
diseases such as AV-block mediates a malfunctional TRPM4 
channel that can generate excessive membrane current during 
cardiac action potentials and the accompanying Ca2+ tran-
sients. Furthermore, we identified the underlying molecular 
mechanism, the intimate interface between the S4-S5 linker 
and the TRP domain is at the center of this malfunction. 
Amino acid exchanges that weaken (unzipping) this inter-
action result in slowed-down Ca2+-dependent activation and 
deactivation kinetics associated with substantially enhanced 
membrane currents, while those strengthening the interac-
tion (zipping) cause augmented kinetics and reduced mem-
brane currents. Human mutations affecting this important 
intramolecular nanodomain can, therefore, alter the cardiac 
myocyte's electrophysiological properties and can cause se-
vere conduction inheritable diseases. Deeper insights into 
such molecular mechanisms by our study may offer new 
pharmacological targets for novel disease management.
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